» Articles » PMID: 27998171

Co-infections of Tuberculosis, Hepatitis B or C Viruses in a Cohort of People Living with HIV/AIDS in China: Predictors and Sequelae

Overview
Journal AIDS Care
Publisher Informa Healthcare
Date 2016 Dec 22
PMID 27998171
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The co-infection of viral hepatitis and tuberculosis (TB) among people living with HIV/AIDS (PLWHA) makes the syndemic of HIV even worse as there is higher mortality and morbidity among PLWHA with co-infections compared to people with HIV mono-infection. In the current study, we explored predictors and sequelae among a group of Chinese PLWHA to guide future program strategies and enhance the repertoire of action for both preventative and clinical purposes. Between October 2012 and August 2013, we conducted a cross-sectional study in Guangxi Autonomous Region (Guangxi) of China. With an overall participation rate of 90%, we finally recruited 3002 patients with 2987 (99.5%) completed the survey and were included in the data analysis. We employed both predictive and explanatory modeling strategies to explore predictors and sequelae of co-infections among PLWHA. The overall prevalence of co-infection was 15.6% with 4.4% of HBV, 5.4% of HCV and 4.8% of TB, respectively. Predictors of co-infections included history of injecting drugs or drinking alcohol, sharing needles, having sex with sex workers or casual partners, higher viral loads and lower CD4 counts. Meanwhile, co-infections were associated with various physical and psychological problems among PLWHA. As an entangled phenomenon, co-infections among PLWHA produce continuous and shifting scenarios, which add complexity to clinic, epidemiological and political ways of dealing with health risks among PLWHA in China. Exploring predictors and sequelae can help to prevent and manage co-infection comorbidities among PLWHA.

Citing Articles

Advanced HIV disease and associated factors among young people aged 15-24 years at a tertiary hospital in Sierra Leone: a cross-sectional study.

Baldeh M, Kizito S, Lakoh S, Sesay D, Williams S, Barrie U BMC Infect Dis. 2024; 24(1):611.

PMID: 38902606 PMC: 11191260. DOI: 10.1186/s12879-024-09524-5.


Prevalence and factors associated with advanced HIV disease among young people aged 15 - 24 years in a national referral hospital in Sierra Leone: A cross-sectional study.

Baldeh M, Kizito S, Lakoh S, Sesay D, Dennis F, Barrie U medRxiv. 2023; .

PMID: 37986831 PMC: 10659455. DOI: 10.1101/2023.11.07.23296880.


Prevalence and risk factors of tuberculosis among people living with HIV/AIDS in China: a systematic review and meta-analysis.

Qi C, Xu L, Zhao C, Zhang H, Li Q, Liu M BMC Infect Dis. 2023; 23(1):584.

PMID: 37674103 PMC: 10481577. DOI: 10.1186/s12879-023-08575-4.


Hepatotoxicity and tuberculosis treatment outcomes in chronic liver disease.

Edwards B, Mah H, Sabur N, Brode S J Assoc Med Microbiol Infect Dis Can. 2023; 8(1):64-74.

PMID: 37008589 PMC: 10052910. DOI: 10.3138/jammi-2022-0029.


Tuberculosis among Ambulatory People Living with HIV in Guangxi Province, China: A Longitudinal Study.

Cui Z, Huang F, Liang D, Huang Y, Qin H, Ye J Int J Environ Res Public Health. 2022; 19(19).

PMID: 36231580 PMC: 9565094. DOI: 10.3390/ijerph191912280.


References
1.
Furin J, Akugizibwe P, Ditiu L, Gray G, Palmero D, Zaidi S . No one with HIV should die from tuberculosis. Lancet. 2015; 386(10010):e48-50. DOI: 10.1016/S0140-6736(15)00319-0. View

2.
Lazarus J, Shete P, Eramova I, Merkinaite S, Matic S . HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management. Int J Drug Policy. 2007; 18(5):426-32. DOI: 10.1016/j.drugpo.2007.01.011. View

3.
. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010; 50(10):1387-96. PMC: 3157754. DOI: 10.1086/652283. View

4.
Alter M . Epidemiology of viral hepatitis and HIV co-infection. J Hepatol. 2005; 44(1 Suppl):S6-9. DOI: 10.1016/j.jhep.2005.11.004. View

5.
Bao Y, Liu Z, Lian Z, Li J, Zhang R, Zhang C . Prevalence and correlates of HIV and HCV infection among amphetamine-type stimulant users in 6 provinces in China. J Acquir Immune Defic Syndr. 2012; 60(4):438-46. DOI: 10.1097/QAI.0b013e31825694f2. View